Trials / Terminated
TerminatedNCT01753830
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
A Multi Center, Randomized, Double Blind, Saline Controlled Study of a Single Injection of Durolane® Versus a Single Injection of Phosphate Buffered Saline (PBS) to Treat Pain Associated With Osteoarthritis of the Knee
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Durolane | 4.5 mL |
| DEVICE | PBS | 4.5 mL |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2012-12-20
- Last updated
- 2022-08-26
- Results posted
- 2020-09-30
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01753830. Inclusion in this directory is not an endorsement.